Evan Norton has left his managing director role at Abbott Ventures, a corporate venturing subsidiary of US-based medical equipment producer Abbott Laboratories, to join healthcare technology-focused investment firm Accelmed Partners.
Norton had spent almost 10 years at Abbott Ventures from 2010, first as director of venture investments, before ascending to lead the unit in 2013. Its areas of focus include medical devices, medical diagnosis tools and pharmaceutical distribution.
Abbott has another strategic investment arm, Abbott Biotech Ventures, which targets biotech and drug developers. The corporate’s most recently disclosed investment was in a $55m series B round for insulin technology producer Bigfoot Biomedical in March 2018.
Accelmed has appointed Norton general partner and he will leverage his experience from his time at Abbott Ventures to oversee investments and identify untapped markets for the firm.
Norton said: “I am delighted to join the seasoned and talented team of Accelmed Partners…With our collective operating and investing experiences, I am confident in our ability to drive continued growth for our portfolio companies and ultimately create significant value for all stakeholders.”
Photo of Evan Norton courtesy of LinkedIn.
